This page contains a Flash digital edition of a book.
PRIME PEOPLE | MICHAEL SHERLING |


MICHAEL SHERLING MODERNIZING MEDICINE


Balraj Juttla talks to Chief Medical Officer and Co-Founder of Modernizing Medicine on how the company was created and their new initiatives for the future


information is created, consumed, and used in order to increase efficiency and improve outcomes. Their EMA™, Electronic Medical Assistant®, is a cloud-based, specialty-specific electronic medical record (EMR) system with a built-in library of medical content. It adapts to each provider’s unique style of practice and is designed to interface with hundreds of different practice management systems. Since they began, the Florida-based company has released the technology across eight different specialties and over one-in-four US dermatologists now use their system. Recently, I had the pleasure of speaking to


M 72 ❚


CMO and co-founder Dr Michael Sherling, on how he and fellow co-founder and CEO Daniel Cane came up with the idea for a new EMR system and what new developments they are currently working on.


How it all started Michael tells me he was a practicing dermatologist in South Florida when Daniel Cane came in one day for a consultation.


March 2015 | prime-journal.com


O D ERNIZIN G Medicine is an award winning company making great strides in


transforming how healthcare


Before he had even spoken, Michael knew there was something different about him. 'Daniel came in and wrote on his in-take


form he was a software entrepreneur, so whenever you read that your interest is immediately piqued. I then asked him what he does and he explained he built educational platforms. My nurse told me she had actually used something he had made and I knew right there and then that he had built something successful and reached many people. I realized he was obviously someone special.' From that first chance encounter, Michael


and Daniel began working together, believing there was a way to bring both their expertise together to improve the way doctors work and the patient experience overall. 'We had an idea of ‘let’s save doctors time’


and build an application that will make doctors faster, and they will want to use it. We built that, earned significant market share and then decided to not just make this about making doctors faster, but rather about improving healthcare quality. That has become the mission of the company.'


Funding for the future Modernizing Medicine recently raised $15 million of funds to finance new initiatives.


The money was raised through existing investors, many of whom are medical practitioners using the EMA system. I was interested to know more about how the money was going to be used to propel the company's growth. 'We have three initiatives. Number one is


supporting the surgical specialties that we are already in. We are currently in eight specialties, which are dermatology, ophthalmology,


orthopedics,


otolaryngology, gastroenterology, plastic surgery, rheumatology, and urology. So we want to add more support and resources to improve the products in these areas' This extra support will come, in large part,


from the 100 new jobs the company is looking to create over the next 12–18 months. These jobs will increase the size of the support teams who look after the over 5000 providers across the US using Modernizing Medicine's technology in their practice. It will also allow them to increase the size of the training teams who will visit the physicians in their practices and teach them how to use EMA correctly and efficiently. 'The second is to fund telemedicine. We


are very interested in moving into the telemedicine space. Because plastic surgery and dermatology are very visual specialties,


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96